Central serous chorioretinopathy after bone marrow transplantation

PURPOSE: To describe central serous chorioretinopathy after bone marrow tra nsplantation. METHODS: The medical records of the patient were reviewed retrospectively. RESULTS: A 46-year-old Filipino man developed multifocal central serous cho rioretinopathy affecting his left eye 4 months after bone marrow transplant ation for acute myelogenous leukemia. Other co-existing medical problems at the time of presentation included systemic hypertension and graft-versus-h ost-disease (GVHD), for which the patient was using both systemic corticost eroids and cyclosporine, CONCLUSION: Central serous chorioretinopathy is a rare cause of vision loss in patients after bone marrow transplantation. Previous descriptions of bo ne marrow transplantation-associated central serous chorioretinopathy in pa tients with thrombotic microangiopathy, as well as the occurrence of both s ystemic hypertension and the use of systemic corticosteroids and cyclospori ne in our patient with bone marrow transplantation-associated central serou s chorioretinopathy, support theories of choroidal vascular compromise in t he pathogenesis of central serous chorioretinopathy. (Am J Ophthalmol 2001; 131:804-805. (C) 2001 by Elsevier Science Inc. All rights reserved.).